Pershing Square Sohn Cancer Research Alliance


The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

Early-Stage Funding for Cancer Research

The Prize for young investigators provides early-stage funding opportunities to New York scientists with innovative ideas in cancer research. The program surrounding the Prize is a catalyst in bridging the gap between the academic scientific community and the business community.

LEARN MORE2019 PRIZE WINNERS

2019 Prize Winners

News

September 6, 2019
HORWITZ PRIZE AWARDED FOR WORK ON CRITICAL CANCER PATHWAY

COLUMBIA UNIVERSITY IRVING MEDICAL CENTER/EUREKALERT – Columbia University will award the 2019 Louisa Gross Horwitz Prize to three scientists:
1.) Lewis C. Cantley, Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY, USA,
2.) David M. Sabatini, Massachusetts Institute of Technology, Cambridge, Massachusetts, and Howard Hughes Medical Institute, Chevy Chase, MD, USA, and
3.) Peter K. Vogt, Scripps Research, La Jolla, CA, USA
for their seminal contributions to the role of the phosphoinositide 3-kinase (PI3K) pathway in physiology and oncogenesis.

Until the end of the 20th century, most cancer therapies worked by attacking replicating cells, an approach that devastated nearly as many normal cells as malignant ones. Discoveries of the processes that control the growth, division, and spread of cancer cells, and the signals that cause these cells to die naturally, gave rise to a new era of targeted therapies–drugs that focus on specific molecular targets associated only with cancer cells.

READ MORE

Events

May 22, 2019 
SIXTH ANNUAL PERSHING SQUARE SOHN PRIZE DINNER

On Wednesday, May 22nd, the Pershing Square Sohn Cancer Research Alliance held its Sixth Annual Prize Dinner at the Consulate General of France in New York, awarding its 2019 Pershing Square Sohn Prize for Young Investigators in Cancer Research to seven early-career pioneers in cancer research in New York City.The evening began with remarks by Consul General Anne-Claire Legendre followed by Olivia Tournay Flatto, PhD, President of The Pershing Square Foundation and Co-founder and Executive Director of the Pershing Square Sohn Cancer Research Alliance. After introductory remarks, Stephanie Oestreich, PhD, Executive Vice President of Evotec and member of the Kendall Square Orchestra, performed a beautiful violin solo. After the entrée, three current Pershing Square Sohn Prize winners were interviewed by The Pershing Square Foundation Co-Trustee and founder, William Ackman.

READ MORE

“The Pershing Square Foundation is proud to support scientific leaders in the fight against cancer.”

Bill Ackman, Co-Founder. The Pershing Square Foundation